Flavio Solca
Impact in
-
- Lung Cancer Treatments and Mutations
- Oncology top 2%
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 32
- Prostate Cancer Treatment and Research 3
- Oncology 24
- HER2/EGFR in Cancer Research 22
- Co-authors
- Frank Himmelsbach (4 shared papers)Anke Baum (7 shared papers)Takeshi Shimamura (2 shared papers)Heidi E. Greulich (3 shared papers)Kwok‐Kin Wong (3 shared papers)Masaya Takahashi (1 shared paper)Matthew Meyerson (1 shared paper)Geoffrey Ira Shapiro (1 shared paper)
- Journals
- Annals of Oncology (11 papers)European Journal of Cancer (5 papers)Molecular Cancer Therapeutics (4 papers)Journal of Thoracic Oncology (4 papers)British Journal of Cancer (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Flavio Solca
82 papers receiving 4.4k citations
Flavio Solca's Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 2k
- Oncology 954
- Otorhinolaryngology 177
- Cancer Research 213
- Molecular Biology 780
Countries citing papers authored by Flavio Solca
This map shows the geographic impact of Flavio Solca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavio Solca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavio Solca more than expected).
Fields of papers citing papers by Flavio Solca
This network shows the impact of papers produced by Flavio Solca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavio Solca. The network helps show where Flavio Solca may publish in the future.
Co-authors
The 25 scholars most cited alongside Flavio Solca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models Hit paper breakdown → | 2008 | 1271 |
| 2 | Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker Hit paper breakdown → | 2012 | 753 |
| 3 | Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. | 1989 | 205 |
| 4 | 2012 | 181 | |
| 5 | 2009 | 158 | |
| 6 | 2012 | 147 | |
| 7 | 2019 | 130 | |
| 8 | 2020 | 123 | |
| 9 | 2014 | 95 | |
| 10 | 2018 | 87 | |
| 11 | 2013 | 86 | |
| 12 | 2017 | 67 | |
| 13 | 2011 | 65 | |
| 14 | 2007 | 61 | |
| 15 | 1989 | 57 | |
| 16 | 1993 | 56 | |
| 17 | 1996 | 49 | |
| 18 | 2020 | 49 | |
| 19 | 2010 | 48 | |
| 20 | 2018 | 48 |
About Flavio Solca
Flavio Solca is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cell Biology, Cellular and Molecular Neuroscience and Otorhinolaryngology, having authored 83 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), HER2/EGFR in Cancer Research (22 papers), melanin and skin pigmentation (9 papers), Neuropeptides and Animal Physiology (8 papers), Head and Neck Cancer Studies (5 papers), Receptor Mechanisms and Signaling (5 papers), Prostate Cancer Treatment and Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2k citations), Oncology (954 citations), Otorhinolaryngology (177 citations), Cancer Research (213 citations) and Molecular Biology (780 citations). Flavio Solca has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Frank Himmelsbach, Anke Baum, Takeshi Shimamura, Heidi E. Greulich, Kwok‐Kin Wong, Masaya Takahashi, Matthew Meyerson, Geoffrey Ira Shapiro, Wolfgang J. Rettig and Lucian R. Chirieac. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Molecular Cancer Therapeutics, Journal of Thoracic Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.